Search Results - "Perazzo, Serena"

Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study by Sacco, Rodolfo, Messina, Vincenzo, Gentilucci, Umberto Vespasiani, Adinolfi, Luigi Elio, Ascione, Antonio, Barbarini, Giorgio, Barlattani, Angelo, Cariti, Giuseppe, Cozzolongo, Raffaele, Fimiani, Basilio, Francavilla, Ruggiero, Furlan, Caterina, Garrucciu, Giovanni, Iovinella, Vincenzo, Rinaldi, Luca, Marignani, Massimo, Begini, Paola, Palitti, Valeria Pace, Pellicelli, Adriano M, Scifo, Gaetano, Facciorusso, Antonio, Giacomelli, Luca, Shah, Aashni, Bertino, Gaetano, Perazzo, Serena, Bresci, Giampaolo, Izzi, Antonio

“…The once-daily oral combination of daclatasvir (DCV) and sofosbuvir (SOF), with or without ribavirin (RBV), is effective and well tolerated in patients with…”
Get full text

Second-line chemotherapy in elderly patients with advanced pancreatic cancer: A mono-institutional retrospective experience by Trovato, Giovanni, Bensi, Maria, Beccia, Viria, Spring, Alexia, Barone, Diletta, Ceccarelli, Anna, Perazzo, Serena, Messina, Gloria, Chiofalo, Laura, Bagalà, Cinzia, Quero, Giuseppe, Alfieri, Sergio, Tortora, Giampaolo, Salvatore, Lisa

“…606 Background: Only few randomized clinical trials have been conducted for second line therapy in advanced pancreatic cancer (APC). In these studies, elderly…”
Get full text

Management of Early-onset Metastatic Colorectal Cancer (ERMIONE): A single institution analysis by Valente, Giustina, Di Bello, Armando, Anghelone, Annunziato, Schietroma, Francesco, Beccia, Viria, Caira, Giulia, Spring, Alexia, Trovato, Giovanni, Ceccarelli, Anna, Chiofalo, Laura, Perazzo, Serena, Bensi, Maria, Basso, Michele, Pozzo, Carmelo, Salvatore, Lisa, Calegari, Maria Alessandra, Tortora, Giampaolo

“…3593 Background: Despite rising incidence and mortality reported worldwide for CRC diagnosed in pts aged < 50 yrs, currently early onset metastatic CRC…”
Get full text

Focus on RAS codon 61 mutations in metastatic colorectal cancer (mCRC): A retrospective analysis by Schietroma, Francesco, Anghelone, Annunziato, Valente, Giustina, Beccia, Viria, Caira, Giulia, Spring, Alexia, Trovato, Giovanni, Di Bello, Armando, Ceccarelli, Anna, Chiofalo, Laura, Perazzo, Serena, Bensi, Maria, Basso, Michele, Pozzo, Carmelo, Salvatore, Lisa, Calegari, Maria Alessandra, Tortora, Giampaolo

“…e15598 Background: Nowadays, RAS mutational status remains a key determinant in mCRC patients’ therapeutic algorithm. Mutations involving codon 61 are rare,…”
Get full text

Focus on RAS Codon 61 Mutations in Metastatic Colorectal Cancer: A Retrospective Analysis by Schietroma, Francesco, Anghelone, Annunziato, Valente, Giustina, Beccia, Viria, Caira, Giulia, Spring, Alexia, Trovato, Giovanni, Di Bello, Armando, Ceccarelli, Anna, Chiofalo, Laura, Perazzo, Serena, Bensi, Maria, Minucci, Angelo, Urbani, Andrea, Larocca, Luigi Maria, Basso, Michele, Pozzo, Carmelo, Salvatore, Lisa, Calegari, Maria Alessandra, Tortora, Giampaolo

“…mutations involving codon 61 are rare in metastatic colorectal cancer (mCRC), accounting for only 1-4%, but they have recently been identified with high…”
Get full text

Focus on IRAS/I Codon 61 Mutations in Metastatic Colorectal Cancer: A Retrospective Analysis by Schietroma, Francesco, Anghelone, Annunziato, Valente, Giustina, Beccia, Viria, Caira, Giulia, Spring, Alexia, Trovato, Giovanni, Di Bello, Armando, Ceccarelli, Anna, Chiofalo, Laura, Perazzo, Serena, Bensi, Maria, Minucci, Angelo, Urbani, Andrea, Larocca, Luigi Maria, Basso, Michele, Pozzo, Carmelo, Salvatore, Lisa, Calegari, Maria Alessandra, Tortora, Giampaolo

“…Codon 61 RAS mutations are rare in metastatic colorectal cancer. Despite being associated with primary and acquired resistance to anti-EGFR agents, little is…”
Get full text